UPDATE: Oppenheimer Starts Vor Biopharma, Inc. (VOR) at Outperform
Tweet Send to a Friend
(Updated - December 1, 2021 4:04 PM EST)
Oppenheimer analyst Matthew Biegler initiates coverage on Vor Biopharma, Inc. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Matthew Biegler initiates coverage on Vor Biopharma, Inc. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
